| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZFHX4 ZNF732 ZIC5 ZBED6 ZNF724 ZNF75D ZNF749 ZNF287 SP140 ZNF445 | 3.12e-06 | 1412 | 162 | 29 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF729 ZNF823 ZNF132 ZNF311 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 NFKBIZ E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZFHX4 ZNF732 ZIC5 ZNF724 ZNF75D ZNF749 TAF1L KDM6A ZNF287 ZNF445 | 5.91e-06 | 1459 | 162 | 29 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF132 ZNF311 ZNF48 ZNF184 NFKBIZ E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZFHX4 ZNF732 ZIC5 ZNF724 ZNF75D KDM6A ZNF287 ZNF445 | 1.81e-04 | 1244 | 162 | 23 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF729 ZNF132 ZNF311 ZNF48 ZNF184 NFKBIZ E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZFHX4 ZNF732 ZIC5 ZNF724 ZNF75D KDM6A ZNF287 ZNF445 | 2.47e-04 | 1271 | 162 | 23 | GO:0000987 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF385A ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 RBSN KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF687 ZNF287 ZNF445 | 9.41e-12 | 775 | 156 | 29 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF385A ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 RBSN KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF687 ZNF287 ZNF445 | 1.00e-11 | 777 | 156 | 29 | PS00028 |
| Domain | Znf_C2H2-like | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF385A ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 RBSN KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF687 ZNF287 ZNF445 | 1.79e-11 | 796 | 156 | 29 | IPR015880 |
| Domain | zf-C2H2 | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF687 ZNF287 ZNF445 | 2.17e-11 | 693 | 156 | 27 | PF00096 |
| Domain | Znf_C2H2 | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF385A ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 RBSN KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF687 ZNF287 ZNF445 | 2.35e-11 | 805 | 156 | 29 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF385A ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 RBSN KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF687 ZNF287 ZNF445 | 2.57e-11 | 808 | 156 | 29 | SM00355 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF729 ZNF823 ZNF132 ZNF311 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF687 ZNF287 ZNF445 | 1.26e-10 | 694 | 156 | 26 | IPR013087 |
| Domain | - | ZNF729 ZNF823 ZNF132 ZNF311 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZFHX4 ZNF732 ZIC5 ZNF75D ZNF749 ZNF445 | 2.23e-09 | 679 | 156 | 24 | 3.30.160.60 |
| Domain | KRAB | ZNF729 ZNF823 ZNF132 ZNF311 ZNF560 ZNF337 ZNF559 ZNF184 ZNF774 ZNF786 ZNF677 ZNF732 ZNF75D ZNF749 ZNF287 ZNF445 | 5.54e-08 | 358 | 156 | 16 | PS50805 |
| Domain | KRAB | ZNF729 ZNF823 ZNF132 ZNF311 ZNF560 ZNF337 ZNF559 ZNF184 ZNF786 ZNF677 ZNF732 ZNF75D ZNF749 ZNF287 ZNF445 | 3.37e-07 | 358 | 156 | 15 | PF01352 |
| Domain | KRAB | ZNF729 ZNF823 ZNF132 ZNF311 ZNF560 ZNF337 ZNF559 ZNF184 ZNF786 ZNF677 ZNF732 ZNF75D ZNF749 ZNF287 ZNF445 | 4.95e-07 | 369 | 156 | 15 | SM00349 |
| Domain | KRAB | ZNF729 ZNF823 ZNF132 ZNF311 ZNF560 ZNF337 ZNF559 ZNF184 ZNF786 ZNF677 ZNF732 ZNF75D ZNF749 ZNF287 ZNF445 | 5.13e-07 | 370 | 156 | 15 | IPR001909 |
| Domain | zf-C2H2_6 | ZNF729 ZNF823 ZNF311 ZNF48 ZNF560 ZNF184 E4F1 ZNF677 ZNF668 ZNF732 ZNF749 ZNF445 | 1.34e-05 | 314 | 156 | 12 | PF13912 |
| Domain | WD40_repeat_dom | 2.02e-04 | 297 | 156 | 10 | IPR017986 | |
| Domain | PTPc | 2.24e-04 | 36 | 156 | 4 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.07e-04 | 39 | 156 | 4 | PS50055 | |
| Domain | PTPase_domain | 3.73e-04 | 41 | 156 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 3.73e-04 | 41 | 156 | 4 | PF00102 | |
| Domain | - | 5.00e-04 | 333 | 156 | 10 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 5.24e-04 | 335 | 156 | 10 | IPR015943 | |
| Pubmed | FAM81B RNPC3 UBR4 ZNF385A DIS3 THAP4 NHSL1 ZNF668 MELTF THADA PTPN11 PHF3 ZNF724 DGKI GFPT2 TAF1L SRSF9 SYMPK | 5.80e-09 | 689 | 165 | 18 | 36543142 | |
| Pubmed | RTEL1 SYNE1 SMC1A CHD8 WNK1 DIS3 C2CD2L PHF3 ERC2 HPS5 SNRNP200 | 1.20e-08 | 225 | 165 | 11 | 12168954 | |
| Pubmed | PNN CHD8 PLEKHA6 WNK1 RBSN HOOK3 KLF10 GTF3C2 PHF3 MYPN PAN2 NONO SRSF9 SNX2 ZNF687 | 2.06e-08 | 503 | 165 | 15 | 16964243 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ENGASE ZNF48 PHF12 UBR4 C19orf47 RAP1GAP2 POMGNT1 CHD8 WNK1 PHC2 C2CD2L NHSL1 THADA KANSL1 EIF4ENIF1 KLF10 PTPRF PTPRS TMEM132A ZNF687 SYMPK | 7.25e-08 | 1105 | 165 | 21 | 35748872 |
| Pubmed | TSHZ3 KBTBD6 PNN PHF12 SMC1A SPTAN1 UBR4 CHD8 MDM2 ZBTB14 KANSL1 EIF4ENIF1 KLF10 GTF3C2 ZFHX4 WDR20 ZNF724 ANKRD17 GFPT2 TAF1L KDM6A ZNF687 SYMPK FBXW7 | 7.87e-08 | 1429 | 165 | 24 | 35140242 | |
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 1.05e-07 | 3 | 165 | 3 | 31985401 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 20139422 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 1.05e-07 | 3 | 165 | 3 | 33656439 | |
| Pubmed | Identification and characterization of three members of a novel subclass of protocadherins. | 1.05e-07 | 3 | 165 | 3 | 11549318 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 9784606 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PNN PHF12 SMC1A SPTAN1 PHC2 NSUN5 NF1 KANSL1 PHF3 ANKRD17 SRSF9 KDM6A SNRNP200 SNX2 CXADR ZNF687 SYMPK | 1.89e-07 | 774 | 165 | 17 | 15302935 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRSF1 ZNF48 PNN PHF12 SMC1A CXXC5 E4F1 ZBTB14 PHC2 THAP4 ZNF668 KANSL1 GTF3C2 ZIC5 PHF3 TAF1L NONO SRSF9 KDM6A SNRNP200 ZNF687 SYMPK | 2.35e-07 | 1294 | 165 | 22 | 30804502 |
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 14967925 | ||
| Pubmed | 4.18e-07 | 4 | 165 | 3 | 8524829 | ||
| Pubmed | ZNF823 IFT140 SYNE1 SPTAN1 RAP1GAP2 CHD8 TRIM21 PLEKHA6 WNK1 MAP3K4 KANSL1 ANKRD17 SNRNP200 | 6.39e-07 | 486 | 165 | 13 | 20936779 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SRSF1 PNN SMC1A SPTAN1 CHD8 TRIM21 NSUN5 NF1 KANSL1 CDC20 NONO SNRNP200 SNX2 SYMPK | 8.26e-07 | 582 | 165 | 14 | 20467437 |
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 10777529 | ||
| Pubmed | 1.04e-06 | 5 | 165 | 3 | 22357843 | ||
| Pubmed | Protein tyrosine phosphatases expression during development of mouse superior colliculus. | 1.11e-06 | 17 | 165 | 4 | 19727691 | |
| Pubmed | 2.08e-06 | 6 | 165 | 3 | 19273906 | ||
| Pubmed | PNN SPTAN1 CHD8 LUZP1 PTPN11 GTF3C2 PHF3 BOD1L1 NONO KDM6A SNRNP200 SNX2 SYMPK | 2.46e-06 | 549 | 165 | 13 | 38280479 | |
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 12376545 | ||
| Pubmed | 3.62e-06 | 7 | 165 | 3 | 29073098 | ||
| Pubmed | BTBD8 SYNE1 RAP1GAP2 MAP3K4 C2CD2L KANSL1 PHF3 PCDH19 ERC2 BOD1L1 PCDH10 | 4.33e-06 | 407 | 165 | 11 | 12693553 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SMC1A SPTAN1 UBR4 CHD8 GTF3C2 PHF3 BOD1L1 NONO SNRNP200 SYMPK | 4.64e-06 | 332 | 165 | 10 | 32786267 |
| Pubmed | COL6A1 TSHZ3 PHF12 UBR4 CHD8 LUZP1 EIF4ENIF1 GTF3C2 ZFHX4 ANKRD17 ZNF687 | 5.58e-06 | 418 | 165 | 11 | 34709266 | |
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 37591863 | ||
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 28637841 | ||
| Pubmed | IFT140 PHF12 CHD8 MDM2 LUZP1 C2CD2L EDEM3 THADA SOWAHA EIF4ENIF1 ZFHX4 PCDH19 WDR20 ANKRD17 CSMD1 SRSF9 ZNF687 SP140 | 6.57e-06 | 1116 | 165 | 18 | 31753913 | |
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 15546961 | ||
| Pubmed | 9.03e-06 | 153 | 165 | 7 | 10718198 | ||
| Pubmed | ZNF48 PHF12 SYNE1 CXXC5 CHD8 E4F1 ZNF385A LUZP1 PHC2 C2CD2L NSUN5 EIF4ENIF1 GTF3C2 ZBED6 PHF3 WDR20 ANKRD17 POLR1B TAF1L NONO ZNF687 | 9.16e-06 | 1497 | 165 | 21 | 31527615 | |
| Pubmed | DENND2A IFT140 PHF12 CHD8 DIS3 GTF3C2 PAN2 ANKRD17 FAM149B1 ARHGAP20 HPS5 ZNF687 | 9.32e-06 | 529 | 165 | 12 | 14621295 | |
| Pubmed | ZNF823 SCFD2 PHF12 UBR4 COLGALT2 FER1L6 ANKRD36B NF1 ANKRD17 GFPT2 KDM6A ZNF687 ACSS3 | 1.23e-05 | 638 | 165 | 13 | 31182584 | |
| Pubmed | SRSF1 PNN SMC1A ZNF184 LUZP1 NSUN5 GTF3C2 PHF3 ANKRD17 POLR1B NONO SRSF9 SNRNP200 ZNF687 SYMPK | 1.37e-05 | 847 | 165 | 15 | 35850772 | |
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 25624497 | ||
| Pubmed | 1.68e-05 | 11 | 165 | 3 | 7832766 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | COL6A1 LRP12 POMGNT1 PGAP4 WDR25 MET EDEM3 GAL MELTF THADA NF1 THY1 PTPRF PTPRS TMEM132A SNX2 CXADR SYMPK | 1.76e-05 | 1201 | 165 | 18 | 35696571 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.03e-05 | 313 | 165 | 9 | 38270169 | |
| Pubmed | Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins. | 2.24e-05 | 12 | 165 | 3 | 9624153 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 8479755 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 29920310 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15182712 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24387768 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7665159 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23592547 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 29099290 | ||
| Pubmed | Global proteomic assessment of the classical protein-tyrosine phosphatome and "Redoxome". | 2.24e-05 | 2 | 165 | 2 | 21884940 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23360489 | ||
| Pubmed | NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome. | 2.24e-05 | 2 | 165 | 2 | 16380919 | |
| Pubmed | A KDM6A-KLF10 reinforcing feedback mechanism aggravates diabetic podocyte dysfunction. | 2.24e-05 | 2 | 165 | 2 | 30948420 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 15601262 | ||
| Pubmed | Independent NF1 and PTPN11 mutations in a family with neurofibromatosis-Noonan syndrome. | 2.24e-05 | 2 | 165 | 2 | 19449407 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 9566880 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 38653581 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SRSF1 PNN SMC1A SPTAN1 UBR4 CHD8 DIS3 COMMD3 LUZP1 NSUN5 NF1 KANSL1 GTF3C2 ANKRD17 POLR1B CDC20 NONO SRSF9 SNRNP200 | 2.49e-05 | 1353 | 165 | 19 | 29467282 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | LRP12 SYNE1 ABCC5 PGAP4 PLEKHA6 COMMD3 CNNM1 RBSN THADA HOOK3 WDR20 GFPT2 SNX2 | 4.24e-05 | 719 | 165 | 13 | 35337019 |
| Pubmed | Agrin has a pathological role in the progression of oral cancer. | 4.59e-05 | 197 | 165 | 7 | 29872149 | |
| Pubmed | The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression. | 5.16e-05 | 84 | 165 | 5 | 26299517 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | CHD8 MAP3K4 NF1 GTF3C2 PHF3 ANKRD17 POLR1B GFPT2 CDC20 ZNF687 | 5.19e-05 | 440 | 165 | 10 | 34244565 |
| Pubmed | SRSF1 SYNE1 SPTAN1 UBR4 CHD8 TRIM21 LUZP1 WDR45 HOOK3 NF1 PTPRD PTPRS ANKRD17 DGKI ERC2 | 5.94e-05 | 963 | 165 | 15 | 28671696 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 16914719 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 36973520 | ||
| Pubmed | PML Suppresses Influenza Virus Replication by Promoting FBXW7 Expression. | 6.69e-05 | 3 | 165 | 2 | 34046815 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 29150959 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 38836326 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 18579758 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 25703008 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 17348023 | ||
| Pubmed | Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion. | 6.69e-05 | 3 | 165 | 2 | 25394468 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 20571051 | ||
| Pubmed | Protein-tyrosine phosphatase expression in pre-B cell NALM-6. | 6.69e-05 | 3 | 165 | 2 | 1370651 | |
| Pubmed | FBXW7 Confers Radiation Survival by Targeting p53 for Degradation. | 6.69e-05 | 3 | 165 | 2 | 31940492 | |
| Pubmed | Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 6.79e-05 | 17 | 165 | 3 | 20301468 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 8.93e-05 | 219 | 165 | 7 | 31353912 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 9.19e-05 | 220 | 165 | 7 | 35785414 | |
| Pubmed | Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. | 9.61e-05 | 19 | 165 | 3 | 20395239 | |
| Pubmed | 9.61e-05 | 19 | 165 | 3 | 25263594 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | PHF12 SMC1A CHD8 TRIM21 GTF3C2 ZFHX4 ZIC5 PHF3 NONO SNRNP200 ZNF687 | 1.15e-04 | 583 | 165 | 11 | 29844126 |
| Pubmed | RTEL1 RNPC3 SMC1A PLEKHA6 WNK1 THADA SACS TMEM132A SNRNP200 PCDH18 | 1.32e-04 | 493 | 165 | 10 | 15368895 | |
| Pubmed | Met acts on Mdm2 via mTOR to signal cell survival during development. | 1.33e-04 | 4 | 165 | 2 | 17329361 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 26231120 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 19120036 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 310441 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 29198712 | ||
| Pubmed | Abl interconnects oncogenic Met and p53 core pathways in cancer cells. | 1.33e-04 | 4 | 165 | 2 | 21455220 | |
| Pubmed | ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer. | 1.33e-04 | 4 | 165 | 2 | 21852383 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 30104724 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 22566641 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 18761340 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 22454513 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 10022843 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRSF1 ZNF48 PNN SMC1A CHD8 ZNF774 LUZP1 PHF3 BOD1L1 TAF1L NONO SRSF9 SNRNP200 SYMPK | 1.95e-04 | 954 | 165 | 14 | 36373674 |
| Pubmed | Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening. | 2.06e-04 | 61 | 165 | 4 | 35205757 | |
| Pubmed | 2.09e-04 | 177 | 165 | 6 | 26206133 | ||
| Pubmed | 2.22e-04 | 5 | 165 | 2 | 2030943 | ||
| Pubmed | 2.22e-04 | 5 | 165 | 2 | 22889954 | ||
| Pubmed | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | 2.22e-04 | 5 | 165 | 2 | 26626481 | |
| Pubmed | The hepatitis delta virus RNA genome interacts with eEF1A1, p54(nrb), hnRNP-L, GAPDH and ASF/SF2. | 2.22e-04 | 5 | 165 | 2 | 19464723 | |
| Pubmed | A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). | 2.22e-04 | 5 | 165 | 2 | 21642990 | |
| Interaction | PCDHGB1 interactions | 2.63e-06 | 77 | 160 | 7 | int:PCDHGB1 | |
| Cytoband | 1q25 | 1.12e-04 | 26 | 165 | 3 | 1q25 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF729 ZNF823 ZNF132 ZNF311 TSHZ3 ZNF48 ZNF560 ZNF337 ZNF559 ZNF184 E4F1 ZNF692 ZNF774 ZNF786 ZBTB14 ZNF677 ZNF668 ZNF594 KLF10 ZNF732 ZIC5 ZNF75D ZNF749 ZNF287 ZNF445 | 4.06e-12 | 718 | 117 | 25 | 28 |
| GeneFamily | Non-clustered protocadherins | 5.57e-05 | 12 | 117 | 3 | 21 | |
| GeneFamily | Ankyrin repeat domain containing | 1.79e-04 | 242 | 117 | 8 | 403 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.23e-04 | 21 | 117 | 3 | 813 | |
| GeneFamily | WD repeat domain containing | 1.59e-03 | 262 | 117 | 7 | 362 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.63e-03 | 12 | 117 | 2 | 737 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 4.13e-03 | 15 | 117 | 2 | 529 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.92e-06 | 166 | 165 | 7 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | COVID-19_Moderate-B_memory|COVID-19_Moderate / disease group, cell group and cell class | 5.35e-06 | 182 | 165 | 7 | bbdbef62389ac062118cc0c7979686393399f2c8 | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.32e-06 | 122 | 165 | 6 | a2f343962069253a08faa80fd70723b8488a99ec | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-06 | 194 | 165 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.59e-06 | 199 | 165 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 9.91e-06 | 200 | 165 | 7 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 9.91e-06 | 200 | 165 | 7 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | Club_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.85e-05 | 159 | 165 | 6 | a7bcff268b1962a561fd2848e01ae16565bce895 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.01e-05 | 169 | 165 | 6 | c8691c4f707d46b2865fe46eabe24ea4d03c7b43 | |
| ToppCell | CV-Mild-6|Mild / Virus stimulation, Condition and Cluster | 4.87e-05 | 175 | 165 | 6 | c4d530dbb37942427c9cd0a1533faeb6a3a45381 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.03e-05 | 176 | 165 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 5.70e-05 | 180 | 165 | 6 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.70e-05 | 180 | 165 | 6 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 184 | 165 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-05 | 185 | 165 | 6 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 189 | 165 | 6 | 544d95df910f1b276995624509a7e41b219baca0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.46e-05 | 189 | 165 | 6 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.46e-05 | 189 | 165 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.68e-05 | 190 | 165 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.91e-05 | 191 | 165 | 6 | 683e5c7e6173644f01e67c98ab7b75d7cb9cce99 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.14e-05 | 192 | 165 | 6 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.14e-05 | 192 | 165 | 6 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.37e-05 | 193 | 165 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 8.37e-05 | 193 | 165 | 6 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.62e-05 | 194 | 165 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 8.62e-05 | 194 | 165 | 6 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 8.86e-05 | 195 | 165 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 195 | 165 | 6 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.11e-05 | 196 | 165 | 6 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.11e-05 | 196 | 165 | 6 | 614a07334707eafe238d5cb7b080a3ca796a1920 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.11e-05 | 196 | 165 | 6 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.37e-05 | 197 | 165 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.37e-05 | 197 | 165 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 9.64e-05 | 198 | 165 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.64e-05 | 198 | 165 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 9.64e-05 | 198 | 165 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.91e-05 | 199 | 165 | 6 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.91e-05 | 199 | 165 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.02e-04 | 200 | 165 | 6 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.02e-04 | 200 | 165 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.02e-04 | 200 | 165 | 6 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-04 | 127 | 165 | 5 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 128 | 165 | 5 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 1.14e-05 | 194 | 163 | 9 | 6778_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | 1.23e-05 | 196 | 163 | 9 | 4591_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.23e-05 | 196 | 163 | 9 | 1494_DN | |
| Drug | Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A | 1.23e-05 | 196 | 163 | 9 | 7520_DN | |
| Drug | Niflumic acid [4394-00-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 1.34e-05 | 198 | 163 | 9 | 5490_DN | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 1.39e-05 | 199 | 163 | 9 | 5787_DN | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.39e-05 | 199 | 163 | 9 | 6002_DN | |
| Drug | geldanamycin | SMC1A PHTF2 MDM2 MET PTPN11 NF1 PTPRD ZFHX4 ZBED6 ERCC6L2 BOD1L1 KDM6A | 1.57e-05 | 371 | 163 | 12 | ctd:C001277 |
| Drug | geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A | 6.03e-05 | 186 | 163 | 8 | 1228_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 6.75e-05 | 189 | 163 | 8 | 6649_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 7.00e-05 | 190 | 163 | 8 | 4322_DN | |
| Drug | Dienestrol [84-17-3]; Up 200; 15uM; MCF7; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 3448_UP | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 4168_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 7.26e-05 | 191 | 163 | 8 | 3890_DN | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; HL60; HT_HG-U133A | 8.40e-05 | 195 | 163 | 8 | 2736_UP | |
| Drug | Betulinic acid [472-15-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 4101_DN | |
| Drug | Primidone [125-33-7]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 5323_UP | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 4965_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; HL60; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 1151_UP | |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | 8.70e-05 | 196 | 163 | 8 | 4984_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; HL60; HG-U133A | 9.01e-05 | 197 | 163 | 8 | 1385_UP | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 5332_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 2892_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 6497_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 9.01e-05 | 197 | 163 | 8 | 1055_UP | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | 9.01e-05 | 197 | 163 | 8 | 4363_DN | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 4410_UP | |
| Drug | Etofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 2256_DN | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 9.34e-05 | 198 | 163 | 8 | 2276_DN | |
| Drug | Xylometazoline hydrochloride [1218-35-5]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 7020_UP | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 9.67e-05 | 199 | 163 | 8 | 4068_DN | |
| Drug | aprikalim | 9.77e-05 | 13 | 163 | 3 | CID003034038 | |
| Disease | triacylglycerol 48:1 measurement | 9.51e-05 | 17 | 157 | 3 | EFO_0010404 | |
| Disease | triacylglycerol 46:1 measurement | 1.58e-04 | 20 | 157 | 3 | EFO_0010401 | |
| Disease | JUVENILE MYELOMONOCYTIC LEUKEMIA | 1.68e-04 | 4 | 157 | 2 | 607785 | |
| Disease | Juvenile myelomonocytic leukemia | 1.68e-04 | 4 | 157 | 2 | cv:C0349639 | |
| Disease | triacylglycerol 48:2 measurement | 2.11e-04 | 22 | 157 | 3 | EFO_0010405 | |
| Disease | juvenile myelomonocytic leukemia (implicated_via_orthology) | 2.78e-04 | 5 | 157 | 2 | DOID:0050458 (implicated_via_orthology) | |
| Disease | Cerebral Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0750936 | |
| Disease | Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.12e-04 | 25 | 157 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 3.12e-04 | 25 | 157 | 3 | C0338070 | |
| Disease | Gemistocytic astrocytoma | 3.51e-04 | 26 | 157 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 3.51e-04 | 26 | 157 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 3.51e-04 | 26 | 157 | 3 | C0334582 | |
| Disease | peak expiratory flow | 3.52e-04 | 498 | 157 | 10 | EFO_0009718 | |
| Disease | Anaplastic astrocytoma | 3.94e-04 | 27 | 157 | 3 | C0334579 | |
| Disease | azoospermia (implicated_via_orthology) | 3.94e-04 | 27 | 157 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ZNF560 SYNE1 ABCC5 WNK1 NF1 PTPRD SACS PTPRS PAN2 KDM6A SNRNP200 FBXW7 | 3.96e-04 | 702 | 157 | 12 | C0009402 |
| Disease | Liposarcoma, well differentiated | 4.16e-04 | 6 | 157 | 2 | C1370889 | |
| Disease | Liposarcoma, Dedifferentiated | 4.16e-04 | 6 | 157 | 2 | C0205824 | |
| Disease | juvenile myelomonocytic leukemia (is_implicated_in) | 5.80e-04 | 7 | 157 | 2 | DOID:0050458 (is_implicated_in) | |
| Disease | bitter alcoholic beverage consumption measurement | 7.44e-04 | 133 | 157 | 5 | EFO_0010092 | |
| Disease | cannabis dependence | 7.96e-04 | 135 | 157 | 5 | EFO_0007191 | |
| Disease | alcohol use disorder measurement | 1.03e-03 | 214 | 157 | 6 | EFO_0009458 | |
| Disease | triacylglycerol 50:3 measurement | 1.17e-03 | 39 | 157 | 3 | EFO_0010410 | |
| Disease | Glioma | 1.22e-03 | 87 | 157 | 4 | C0017638 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.36e-03 | 41 | 157 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | telomere length | 1.49e-03 | 313 | 157 | 7 | EFO_0004505 | |
| Disease | NG-monomethyl-arginine measurement | 1.50e-03 | 11 | 157 | 2 | EFO_0010510 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.79e-03 | 12 | 157 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | Congenital muscular dystrophy | 1.79e-03 | 12 | 157 | 2 | cv:C0699743 | |
| Disease | Malignant neoplasm of breast | SRSF1 SYNE1 SPTAN1 UBR4 COLGALT2 MDM2 WNK1 OR1N1 ZNF668 HOOK3 NF1 PTPRD BOD1L1 FBXW7 | 1.85e-03 | 1074 | 157 | 14 | C0006142 |
| Disease | Adenoid Cystic Carcinoma | 2.04e-03 | 100 | 157 | 4 | C0010606 | |
| Disease | plasma beta-amyloid 1-42 measurement | 2.11e-03 | 13 | 157 | 2 | EFO_0005660 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.11e-03 | 13 | 157 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Modic type vertebral endplate changes | 2.11e-03 | 13 | 157 | 2 | HP_0030775 | |
| Disease | melanoma | 2.18e-03 | 248 | 157 | 6 | C0025202 | |
| Disease | triacylglycerol 46:2 measurement | 2.45e-03 | 14 | 157 | 2 | EFO_0010402 | |
| Disease | triacylglycerol 46:0 measurement | 2.82e-03 | 15 | 157 | 2 | EFO_0010400 | |
| Disease | RASopathy | 2.82e-03 | 15 | 157 | 2 | cv:C5555857 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.63e-03 | 17 | 157 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | irritable bowel syndrome symptom measurement | 3.68e-03 | 58 | 157 | 3 | EFO_0021536 | |
| Disease | diet measurement | IFT57 DIS3 THADA DEFB112 NF1 PTPRF PCDHGB4 DGKI ERC2 CSMD1 PCDH10 ZNF287 ACSS3 | 4.11e-03 | 1049 | 157 | 13 | EFO_0008111 |
| Disease | uterine fibroid | 4.33e-03 | 199 | 157 | 5 | EFO_0000731 | |
| Disease | Juvenile Myelomonocytic Leukemia | 4.53e-03 | 19 | 157 | 2 | C0349639 | |
| Disease | platelet crit | SCFD2 DENND2A RTEL1 CXXC5 ABCC5 PLEKHA6 THADA NF1 KANSL1 WDR20 POLR1B SNX2 | 5.06e-03 | 952 | 157 | 12 | EFO_0007985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLSRHKKSRGAGELA | 296 | Q96PM9 | |
| SDAFATFKDLLTRHK | 181 | Q9H9S4 | |
| REREKASAAKSSLIH | 481 | Q12834 | |
| VRKQTRHFSTLKDDD | 1401 | Q9HCK8 | |
| SRLAAAIGKHSESVK | 611 | Q5CZ79 | |
| RLGDDFKTKSLLRFS | 2931 | Q96PZ7 | |
| LHRTSVFDRLGAETK | 236 | Q8N9M1 | |
| RKREVELFVLHSKTG | 581 | Q96NN9 | |
| TLSHDTRRSKGLKIE | 61 | Q8N268 | |
| KGSATKALLDASSRH | 1256 | Q8N2N9 | |
| KHGESSLDIARRLKF | 166 | Q5VYY1 | |
| TLLERGASIEHRDKK | 1101 | O75179 | |
| ALHSLEFSRTDKLKS | 266 | Q9P1Z9 | |
| ESRSARLRKSGKEHI | 181 | Q5BKX8 | |
| NLLGKADTVSHKFRR | 781 | Q9UPM8 | |
| KLGRLSLLKAFSRHE | 296 | Q2M243 | |
| LGAVRSHLSDFKKHR | 96 | Q9H1K0 | |
| SSLDDLRALKGKHFL | 166 | Q96P11 | |
| TVLKIRSVSGRHKAF | 226 | Q8NGL3 | |
| GTHIALLKVRDKDSR | 361 | Q9UN71 | |
| TFKIDSERGHLTLFK | 296 | Q9HCL0 | |
| KRSATKALLDASSRH | 1681 | Q5JPF3 | |
| KKAHSTEGRRLTDLN | 506 | Q9NRJ5 | |
| RAHLIKSSSTFKDLE | 886 | Q8TAB3 | |
| GKVSLRDLRTFKVEH | 216 | Q504Q3 | |
| HKDKGFGFIRLETRT | 106 | Q15233 | |
| TGDHRKVILRFTDFK | 291 | Q9Y561 | |
| EAKDRKSGRTALHLA | 606 | Q9BYH8 | |
| AEKAFTRSINRDKHL | 56 | P19878 | |
| VLHELSGDKSLEKFR | 26 | Q5T655 | |
| GLDLSKHKETRGFVA | 671 | Q9BZQ6 | |
| ASRARKTLTADKLEH | 386 | Q9UPZ3 | |
| RFHEDGARTKALLGK | 61 | O15550 | |
| TTEDLFAAIHRSKRK | 1356 | Q5SYE7 | |
| DRKRRDTSGLERSHK | 651 | Q9H307 | |
| ILCRIREHSSEGKSK | 221 | Q8IXE1 | |
| PDSARKDRHKLVSSF | 716 | Q7Z3B3 | |
| LKEHASSLASAGLKR | 646 | O15083 | |
| VERSVSHFDAKLLSK | 146 | Q9BRR3 | |
| LTEKGKHGSFLVRES | 126 | Q06124 | |
| STFGKEKALHSTLER | 1001 | Q9P2E7 | |
| LHKKAAEDRLASTGS | 676 | Q86VS8 | |
| HKSGAVASLLSKAER | 136 | Q7LFL8 | |
| VRTFSLHKNGSSEKR | 1531 | Q13332 | |
| THGFRKEESLARKLL | 146 | Q96LP2 | |
| FVKGTLRASSRLHDE | 936 | O15440 | |
| RLERKLSDGHKSRSL | 1011 | Q8NFC6 | |
| LEAGKHRADKSTLST | 71 | Q9UBI1 | |
| HRSGIESALKETKGF | 271 | Q9NWB7 | |
| EIEFSHRSRKRSDGK | 41 | Q86Z20 | |
| ADGKLSIHRVKRSAS | 286 | O94808 | |
| ALETRSLKDHKVSFL | 626 | O14523 | |
| GSHNFDTTKRFAKRL | 841 | P12109 | |
| EAFRKAVSSKSLRHF | 931 | Q9ULE3 | |
| ERLSKFESIRHSIAG | 416 | P16591 | |
| DFLQRSSRDLSKHVK | 571 | O75912 | |
| HRSFSDKNGLTSKRE | 51 | P22466 | |
| FVDGKRFKAHRAILS | 211 | Q5XKL5 | |
| DLKGRVHFTSNDLKS | 86 | P78310 | |
| FEKARHGTEKISTAR | 26 | Q30KQ8 | |
| KLDHGSEVRSFSLGK | 171 | Q969H0 | |
| KRDTHFTIEDLKSLG | 641 | Q5U5Z8 | |
| EDAFLSSKGRHERTK | 361 | Q86V48 | |
| FTKRKRLSAEEAHLG | 441 | Q6MZM0 | |
| LSRHRRTHTGEKKFA | 416 | Q13118 | |
| RFDTDKSLELIRKHG | 341 | Q8NFI3 | |
| SFRESGALTRHLKSL | 256 | Q66K89 | |
| KFEEKHLSSLSAIRE | 326 | Q9H069 | |
| SFLAAVLHKKGTRED | 171 | Q5T890 | |
| HSTFLIDLRKEASDK | 236 | Q8IYK4 | |
| EKSAERSTQGLKFHL | 111 | Q92681 | |
| FRVTSSESKALKHER | 331 | Q9NZJ4 | |
| AHFKSFDLSRREAKA | 541 | Q96RY7 | |
| ILKFADAFGHRKLRS | 176 | Q86V97 | |
| RTFALHKSGSSEKRE | 1491 | P10586 | |
| LEFKRLASSKAHTSR | 1646 | P23468 | |
| SIFNLGRSGHETKRK | 291 | Q7Z6I6 | |
| ERDSTIFGIRGKKLH | 176 | Q96BN6 | |
| KGALKRLFSHRSIVS | 296 | Q8NGS0 | |
| HEARERASKALGFAK | 806 | Q9Y6R4 | |
| RSKLLTKIHDGEVRS | 66 | Q2WGJ9 | |
| LHSISVRRLKETKDG | 211 | P08581 | |
| SDSGHKTFKRRRSII | 321 | Q9P2F6 | |
| DAKSRRAHNIDLKGT | 231 | Q9NZ71 | |
| KRRFSDFLGLHSKLA | 181 | O60749 | |
| KLFGHLTSARRARKS | 586 | Q8N3S3 | |
| ITRIFGVKRAKDEHS | 1261 | Q6YHU6 | |
| RSNLKFRFDKLSHAS | 711 | Q684P5 | |
| ALRKLDDTKFRSHEG | 161 | Q13242 | |
| SSHAFTLDELRGKRS | 461 | P08582 | |
| HSLLKSAREKGERAV | 3761 | Q8NF91 | |
| AKLDRFKGSRHHTTL | 311 | Q24JP5 | |
| EGRFREKASILHKIA | 376 | Q9UI40 | |
| TGKFRSLLESHSSKL | 56 | P58872 | |
| KAFPSHSESSIRKRL | 851 | Q8IZX4 | |
| GSFHLKDTAKALLRS | 181 | Q8WZA1 | |
| RKRHKSDSISLSFDE | 181 | Q00987 | |
| RSASKTELKAIAHAR | 141 | Q96QT6 | |
| LFRGETGKDREKSHS | 226 | Q969X2 | |
| FIDDKGILFVSSRKH | 86 | Q5VXU9 | |
| DALHTKAGSRRLTEL | 146 | Q9Y6E7 | |
| AALRKKHADSVAELG | 1191 | P11055 | |
| SDKGTVHIFALKDTR | 256 | Q9Y484 | |
| SGVSKFATLSLHDRK | 456 | Q8TBZ3 | |
| HKSKIAVDELFTSLR | 531 | Q8WU76 | |
| SKSDIKESRRHLFTP | 361 | Q9Y2L1 | |
| ISARTFEKDHRLSDK | 161 | Q9NRA8 | |
| GFASKELSSRIDHVK | 201 | Q9H6R3 | |
| RNLSEKLKGSHSSFD | 101 | Q8N957 | |
| KSHFSRLSEEKLALD | 36 | Q5T681 | |
| RKRHDFSLFKLSDTE | 586 | Q9NRU3 | |
| SVRRLREKFHGKVSS | 11 | Q9NUL5 | |
| KENKDHSLERGRASL | 6 | P17752 | |
| TRTARKAVAFGKRSH | 36 | Q9Y2H5 | |
| FSDEGRLRKHEKLHT | 286 | O43829 | |
| GKAFTRSRFLRGHEK | 561 | P16415 | |
| GKAFSERSTLVRHQK | 661 | P52740 | |
| RVGLFHSDRSKLQKA | 676 | Q8IXK0 | |
| RALFKAKSALESHIR | 2636 | Q86UP3 | |
| KGFADSSARVKHLRT | 486 | Q96MX3 | |
| KHDTAAVDRSVKRLF | 326 | Q9H900 | |
| TDAFSKRSDLIQHKR | 461 | O43361 | |
| GKAFKRSSNLTEHRI | 456 | A8MTY0 | |
| KSFSDRAGLRKHSRT | 551 | Q96K58 | |
| KIHTDERGFSLKSVL | 286 | Q9HBT7 | |
| RVLSDKGRLKHTAFA | 56 | Q96LT9 | |
| HGGKVRNSELLSRFK | 26 | Q2M3V2 | |
| RKAKLGDSHDLQRFL | 1331 | Q13813 | |
| KGFKQSSDLVTHRRT | 186 | Q6NX45 | |
| EFSLTRETKKHVLFG | 51 | P04216 | |
| KLLGTRKSFDHLISD | 2536 | P21359 | |
| SREEGHKDKERARLS | 1961 | Q92576 | |
| HRLKEEASKRAATLA | 376 | Q14683 | |
| EAEKRVKASHSFLRG | 16 | Q9H115 | |
| DSVRRKGHFLLSSKS | 361 | P19474 | |
| ESHLGFRLRDLSKLS | 996 | Q63HK5 | |
| SSHEKDKVRSQALLF | 721 | Q92797 | |
| DKAFAERSSLTQHKR | 381 | Q86XU0 | |
| HSRKETGKTARAIRD | 726 | O75643 | |
| GKGFTRQSKLTEHLR | 571 | Q8N393 | |
| KHDKSASDALRAERG | 231 | P86452 | |
| GKSFRVSSDLIKHHR | 371 | P51815 | |
| GKTFTRKRTLLDHKG | 846 | P59923 | |
| KSFRGSSDLIKHHRI | 631 | Q96JF6 | |
| GKRTFSSRLILEKHV | 1031 | Q8N1G0 | |
| RSRASRKHKDETVDF | 571 | Q13342 | |
| AVRKLDNTKFRSHEG | 171 | Q07955 | |
| SHFLVSAGSDRKIKF | 626 | Q8WUA4 | |
| RSDFRITTLKFHPKD | 331 | Q64LD2 | |
| SRKGTFTDDLHKLVD | 2241 | Q9H4A3 | |
| GKAFSRFTTLNEHKR | 396 | B4DXR9 | |
| DKFASRHGQKGILSR | 881 | Q9H9Y6 | |
| VESIKRHFKSRLVGT | 4251 | Q5T4S7 | |
| GKAFTDSSGLIKHRR | 331 | Q9BR84 | |
| HFKLSEQEGSRSKLA | 296 | Q7Z769 | |
| TKDSFSKRLEDQHRL | 61 | Q8WY91 | |
| LEEKGRFSSFLSRSK | 71 | A0A0B4J238 | |
| RFEKPDSVAAHRSKS | 456 | Q9BU19 | |
| GKAFIRSSSLAKHER | 536 | Q99676 | |
| GKAFTERSDLTKHLR | 606 | Q96MR9 | |
| KRGYTSKSDLTVHER | 691 | Q9Y3M9 | |
| GRAFSRSSDLSKHKR | 421 | Q5JNZ3 | |
| FSALRRHKIIHTGEK | 696 | A6NN14 | |
| KGHSRDFVLRRDLSA | 191 | Q96T25 | |
| IFDKRLKHFRVTEGS | 946 | Q86TC9 |